image
Cidara Therapeutics, Inc. CDTX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 14.37
-0.76 %
$ 101 M
Market Cap
-0.6
P/E
INCOME STATEMENT
63.9 M REVENUE
-0.60%
Growth Rates
1Year -0.60%
3Years 74.31%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-24.5 M OPERATING INCOME
17.62%
Growth Rates
1Year 17.62%
3Years 30.15%
5Years 17.30%
7Years 9.29%
10Years -36.60%
-22.9 M NET INCOME
23.05%
Growth Rates
1Year 23.05%
3Years 31.74%
5Years 17.23%
7Years 10.06%
10Years -32.80%
EFFICIENCY
Earnings Waterfall Cidara Therapeutics, Inc.
image
Revenue 63.9 M
Cost Of Revenue 1.52 M
Gross Profit 62.4 M
Operating Expenses 86.9 M
Operating Income -24.5 M
Other Expenses -1.55 M
Net Income -22.9 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
REVENUE
Revenue 63.9 64.3 49.6 12.1 20.9 0 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 1.5 0.1 0.2 68.0 46.4 0.5 0.7 0.7 0.5 0 0 0
Gross Profit 62.4 64.1 49.4 (56.0) (25.5) (0.5) (0.7) (0.7) (0.5) 0 0 0
OPERATING INCOME
Operating Expenses 86.9 94.0 91.8 83.9 62.6 63.3 55.7 48.4 32.3 10.0 1.1 0.8
Selling, General and Administrative Expenses 18.3 18.5 18.7 15.9 16.2 14.1 12.9 12.7 8.8 3.3 0.3 0.8
Research and Development Expenses 68.5 75.5 73.1 68.0 46.4 49.1 42.8 35.7 23.5 6.7 0.8 12 K
Operating Income (24.5) (29.7) (42.3) (71.8) (41.7) (63.3) (55.7) (48.4) (32.3) (11.6) (1.1) (0.8)
PRE-TAX INCOME
Interest Income Expense 0 0.2 0.2 0.3 0.2 0.6 7 K 0.3 0.1 0 0 0
Total Other Income 2.0 0.2 (0.2) (0.3) 0.6 4.3 7 K 0.3 0.1 (1.9) (0.3) 0
Pre-Tax Income (22.5) (29.5) (42.5) (72.1) (41.1) (59.0) (55.7) (48.2) (32.2) (11.9) (1.3) (0.8)
NET INCOME
Tax Provision 0.4 0.3 1.4 0.3 (1.0) 4.3 (0.7) (0.7) (0.5) 1.7 (1.0) 0
Net Income (22.9) (29.8) (43.9) (72.4) (40.1) (59.0) (55.7) (48.2) (32.2) (11.9) (1.3) (0.8)
EPS 5.25 8.53 16.8 34.8 26.8 45.6 63.7 66.5 46.8 290 83 44.7